ARCHIVES

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

This article is from The Cancer Letter archive.

Vol. 03 No. 24 | June 17, 1977

Download PDF Visit The Full Archive

Related Articles

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

New research Suggested For Immunobiology

November 18, 1977

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

Report Criticizes NIH Grant Review

June 16, 1995

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006